Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Bioreactor systems are essentially required for stem cell bioprocessing

Cha JM, Lee MY, Hong J

As stem cell technologies have rapidly advanced, the stem cell therapy market has been forecast to reach hundreds of millions of USD in market value within the next 5 years....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronic insomnia disorder: perspectives from structural neuroimaging

Joo EY

Chronic insomnia disorder is the most widely reported clinical condition in medicine. It has a significant impact on populations and is characterized by chronically disturbed sleep and sleep loss, non-refreshing...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updates on structural neuroimaging of narcolepsy with cataplexy

Joo EY

Narcolepsy is a chronic neurological disorder associated with abnormal regulation of the sleep-wake cycle, resulting in excessive daytime sleepiness, disturbed nocturnal sleep, and rapid eye movement (REM) sleep phenomena including...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Isolated monocytosis was the flag preceding abnormalities in other parameters of complete blood counts in chronic myeloid leukemia with e1a2 (minor, P190) BCR-ABL1 chimeric transcripts

Yun JW, Yoon J, Kim JW, Kim SH, Jung CW, Kim HJ

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm with the molecular hallmark of BCR-ABL1 chimeric transcripts from t(9;22)(q24;q22). In more than 95% of CML, the fusion occurs in the major...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial

Park SH, Lee J, Sohn TS, Lim DH, Kim KM, An JY, Choi MG, Lee JH, Bae JM, Kim S, Lee SJ, Kim ST, Park JO, Park YS, Lim HY, Kang WK

PURPOSE: The Adjuvant chemoRadioTherapy In Stomach Tumors 2 (ARTIST 2) trial was conducted to compare the efficacy between adjuvant chemotherapy regimens and chemoradiotherapy in D2-resected, node-positive, stage 2 or 3...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr